- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.
According to our latest study, the global Soliris (Eculizumab) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In Asia-Pacific, Japan is the largest Soliris (Eculizumab) market with about 32% market share. China is follower, accounting for about 25% market share.The key manufacturers are Alexion etc.
This report is a detailed and comprehensive analysis for global Soliris (Eculizumab) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Soliris (Eculizumab) market size and forecasts, in consumption value ($ Million), 2018-2029
Global Soliris (Eculizumab) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Soliris (Eculizumab) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Soliris (Eculizumab) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Soliris (Eculizumab)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Soliris (Eculizumab) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alexion... etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Soliris (Eculizumab) market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Plasma Exchange
Plasma Infusion
Market segment by Application
PNH
aHUS
Others
Market segment by players, this report covers
Alexion
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Soliris (Eculizumab) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Soliris (Eculizumab), with revenue, gross margin and global market share of Soliris (Eculizumab) from 2018 to 2023.
Chapter 3, the Soliris (Eculizumab) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Soliris (Eculizumab) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Soliris (Eculizumab).
Chapter 13, to describe Soliris (Eculizumab) research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Soliris (Eculizumab)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Soliris (Eculizumab) by Type
1.3.1 Overview: Global Soliris (Eculizumab) Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Soliris (Eculizumab) Consumption Value Market Share by Type in 2022
1.3.3 Plasma Exchange
1.3.4 Plasma Infusion
1.4 Global Soliris (Eculizumab) Market by Application
1.4.1 Overview: Global Soliris (Eculizumab) Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 PNH
1.4.3 aHUS
1.4.4 Others
1.5 Global Soliris (Eculizumab) Market Size & Forecast
1.6 Global Soliris (Eculizumab) Market Size and Forecast by Region
1.6.1 Global Soliris (Eculizumab) Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Soliris (Eculizumab) Market Size by Region, (2018-2029)
1.6.3 North America Soliris (Eculizumab) Market Size and Prospect (2018-2029)
1.6.4 Europe Soliris (Eculizumab) Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Soliris (Eculizumab) Market Size and Prospect (2018-2029)
1.6.6 South America Soliris (Eculizumab) Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Soliris (Eculizumab) Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Alexion
2.1.1 Alexion Details
2.1.2 Alexion Major Business
2.1.3 Alexion Soliris (Eculizumab) Product and Solutions
2.1.4 Alexion Soliris (Eculizumab) Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Alexion Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Soliris (Eculizumab) Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Soliris (Eculizumab) by Company Revenue
3.2.2 Top 3 Soliris (Eculizumab) Players Market Share in 2022
3.2.3 Top 6 Soliris (Eculizumab) Players Market Share in 2022
3.3 Soliris (Eculizumab) Market: Overall Company Footprint Analysis
3.3.1 Soliris (Eculizumab) Market: Region Footprint
3.3.2 Soliris (Eculizumab) Market: Company Product Type Footprint
3.3.3 Soliris (Eculizumab) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Soliris (Eculizumab) Consumption Value and Market Share by Type (2018-2023)
4.2 Global Soliris (Eculizumab) Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Soliris (Eculizumab) Consumption Value Market Share by Application (2018-2023)
5.2 Global Soliris (Eculizumab) Market Forecast by Application (2024-2029)
6 North America
6.1 North America Soliris (Eculizumab) Consumption Value by Type (2018-2029)
6.2 North America Soliris (Eculizumab) Consumption Value by Application (2018-2029)
6.3 North America Soliris (Eculizumab) Market Size by Country
6.3.1 North America Soliris (Eculizumab) Consumption Value by Country (2018-2029)
6.3.2 United States Soliris (Eculizumab) Market Size and Forecast (2018-2029)
6.3.3 Canada Soliris (Eculizumab) Market Size and Forecast (2018-2029)
6.3.4 Mexico Soliris (Eculizumab) Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Soliris (Eculizumab) Consumption Value by Type (2018-2029)
7.2 Europe Soliris (Eculizumab) Consumption Value by Application (2018-2029)
7.3 Europe Soliris (Eculizumab) Market Size by Country
7.3.1 Europe Soliris (Eculizumab) Consumption Value by Country (2018-2029)
7.3.2 Germany Soliris (Eculizumab) Market Size and Forecast (2018-2029)
7.3.3 France Soliris (Eculizumab) Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Soliris (Eculizumab) Market Size and Forecast (2018-2029)
7.3.5 Russia Soliris (Eculizumab) Market Size and Forecast (2018-2029)
7.3.6 Italy Soliris (Eculizumab) Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Soliris (Eculizumab) Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Soliris (Eculizumab) Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Soliris (Eculizumab) Market Size by Region
8.3.1 Asia-Pacific Soliris (Eculizumab) Consumption Value by Region (2018-2029)
8.3.2 China Soliris (Eculizumab) Market Size and Forecast (2018-2029)
8.3.3 Japan Soliris (Eculizumab) Market Size and Forecast (2018-2029)
8.3.4 South Korea Soliris (Eculizumab) Market Size and Forecast (2018-2029)
8.3.5 India Soliris (Eculizumab) Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Soliris (Eculizumab) Market Size and Forecast (2018-2029)
8.3.7 Australia Soliris (Eculizumab) Market Size and Forecast (2018-2029)
9 South America
9.1 South America Soliris (Eculizumab) Consumption Value by Type (2018-2029)
9.2 South America Soliris (Eculizumab) Consumption Value by Application (2018-2029)
9.3 South America Soliris (Eculizumab) Market Size by Country
9.3.1 South America Soliris (Eculizumab) Consumption Value by Country (2018-2029)
9.3.2 Brazil Soliris (Eculizumab) Market Size and Forecast (2018-2029)
9.3.3 Argentina Soliris (Eculizumab) Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Soliris (Eculizumab) Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Soliris (Eculizumab) Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Soliris (Eculizumab) Market Size by Country
10.3.1 Middle East & Africa Soliris (Eculizumab) Consumption Value by Country (2018-2029)
10.3.2 Turkey Soliris (Eculizumab) Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Soliris (Eculizumab) Market Size and Forecast (2018-2029)
10.3.4 UAE Soliris (Eculizumab) Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Soliris (Eculizumab) Market Drivers
11.2 Soliris (Eculizumab) Market Restraints
11.3 Soliris (Eculizumab) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Soliris (Eculizumab) Industry Chain
12.2 Soliris (Eculizumab) Upstream Analysis
12.3 Soliris (Eculizumab) Midstream Analysis
12.4 Soliris (Eculizumab) Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Soliris (Eculizumab) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Soliris (Eculizumab) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Soliris (Eculizumab) Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Soliris (Eculizumab) Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Alexion Company Information, Head Office, and Major Competitors
Table 6. Alexion Major Business
Table 7. Alexion Soliris (Eculizumab) Product and Solutions
Table 8. Alexion Soliris (Eculizumab) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Alexion Recent Developments and Future Plans
Table 10. Global Soliris (Eculizumab) Revenue (USD Million) by Players (2018-2023)
Table 11. Global Soliris (Eculizumab) Revenue Share by Players (2018-2023)
Table 12. Breakdown of Soliris (Eculizumab) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 13. Market Position of Players in Soliris (Eculizumab), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 14. Head Office of Key Soliris (Eculizumab) Players
Table 15. Soliris (Eculizumab) Market: Company Product Type Footprint
Table 16. Soliris (Eculizumab) Market: Company Product Application Footprint
Table 17. Soliris (Eculizumab) New Market Entrants and Barriers to Market Entry
Table 18. Soliris (Eculizumab) Mergers, Acquisition, Agreements, and Collaborations
Table 19. Global Soliris (Eculizumab) Consumption Value (USD Million) by Type (2018-2023)
Table 20. Global Soliris (Eculizumab) Consumption Value Share by Type (2018-2023)
Table 21. Global Soliris (Eculizumab) Consumption Value Forecast by Type (2024-2029)
Table 22. Global Soliris (Eculizumab) Consumption Value by Application (2018-2023)
Table 23. Global Soliris (Eculizumab) Consumption Value Forecast by Application (2024-2029)
Table 24. North America Soliris (Eculizumab) Consumption Value by Type (2018-2023) & (USD Million)
Table 25. North America Soliris (Eculizumab) Consumption Value by Type (2024-2029) & (USD Million)
Table 26. North America Soliris (Eculizumab) Consumption Value by Application (2018-2023) & (USD Million)
Table 27. North America Soliris (Eculizumab) Consumption Value by Application (2024-2029) & (USD Million)
Table 28. North America Soliris (Eculizumab) Consumption Value by Country (2018-2023) & (USD Million)
Table 29. North America Soliris (Eculizumab) Consumption Value by Country (2024-2029) & (USD Million)
Table 30. Europe Soliris (Eculizumab) Consumption Value by Type (2018-2023) & (USD Million)
Table 31. Europe Soliris (Eculizumab) Consumption Value by Type (2024-2029) & (USD Million)
Table 32. Europe Soliris (Eculizumab) Consumption Value by Application (2018-2023) & (USD Million)
Table 33. Europe Soliris (Eculizumab) Consumption Value by Application (2024-2029) & (USD Million)
Table 34. Europe Soliris (Eculizumab) Consumption Value by Country (2018-2023) & (USD Million)
Table 35. Europe Soliris (Eculizumab) Consumption Value by Country (2024-2029) & (USD Million)
Table 36. Asia-Pacific Soliris (Eculizumab) Consumption Value by Type (2018-2023) & (USD Million)
Table 37. Asia-Pacific Soliris (Eculizumab) Consumption Value by Type (2024-2029) & (USD Million)
Table 38. Asia-Pacific Soliris (Eculizumab) Consumption Value by Application (2018-2023) & (USD Million)
Table 39. Asia-Pacific Soliris (Eculizumab) Consumption Value by Application (2024-2029) & (USD Million)
Table 40. Asia-Pacific Soliris (Eculizumab) Consumption Value by Region (2018-2023) & (USD Million)
Table 41. Asia-Pacific Soliris (Eculizumab) Consumption Value by Region (2024-2029) & (USD Million)
Table 42. South America Soliris (Eculizumab) Consumption Value by Type (2018-2023) & (USD Million)
Table 43. South America Soliris (Eculizumab) Consumption Value by Type (2024-2029) & (USD Million)
Table 44. South America Soliris (Eculizumab) Consumption Value by Application (2018-2023) & (USD Million)
Table 45. South America Soliris (Eculizumab) Consumption Value by Application (2024-2029) & (USD Million)
Table 46. South America Soliris (Eculizumab) Consumption Value by Country (2018-2023) & (USD Million)
Table 47. South America Soliris (Eculizumab) Consumption Value by Country (2024-2029) & (USD Million)
Table 48. Middle East & Africa Soliris (Eculizumab) Consumption Value by Type (2018-2023) & (USD Million)
Table 49. Middle East & Africa Soliris (Eculizumab) Consumption Value by Type (2024-2029) & (USD Million)
Table 50. Middle East & Africa Soliris (Eculizumab) Consumption Value by Application (2018-2023) & (USD Million)
Table 51. Middle East & Africa Soliris (Eculizumab) Consumption Value by Application (2024-2029) & (USD Million)
Table 52. Middle East & Africa Soliris (Eculizumab) Consumption Value by Country (2018-2023) & (USD Million)
Table 53. Middle East & Africa Soliris (Eculizumab) Consumption Value by Country (2024-2029) & (USD Million)
Table 54. Soliris (Eculizumab) Raw Material
Table 55. Key Suppliers of Soliris (Eculizumab) Raw Materials
List of Figures
Figure 1. Soliris (Eculizumab) Picture
Figure 2. Global Soliris (Eculizumab) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Soliris (Eculizumab) Consumption Value Market Share by Type in 2022
Figure 4. Plasma Exchange
Figure 5. Plasma Infusion
Figure 6. Global Soliris (Eculizumab) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Soliris (Eculizumab) Consumption Value Market Share by Application in 2022
Figure 8. PNH Picture
Figure 9. aHUS Picture
Figure 10. Others Picture
Figure 11. Global Soliris (Eculizumab) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Soliris (Eculizumab) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Soliris (Eculizumab) Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Soliris (Eculizumab) Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Soliris (Eculizumab) Consumption Value Market Share by Region in 2022
Figure 16. North America Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Soliris (Eculizumab) Revenue Share by Players in 2022
Figure 22. Soliris (Eculizumab) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Soliris (Eculizumab) Market Share in 2022
Figure 24. Global Top 6 Players Soliris (Eculizumab) Market Share in 2022
Figure 25. Global Soliris (Eculizumab) Consumption Value Share by Type (2018-2023)
Figure 26. Global Soliris (Eculizumab) Market Share Forecast by Type (2024-2029)
Figure 27. Global Soliris (Eculizumab) Consumption Value Share by Application (2018-2023)
Figure 28. Global Soliris (Eculizumab) Market Share Forecast by Application (2024-2029)
Figure 29. North America Soliris (Eculizumab) Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Soliris (Eculizumab) Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Soliris (Eculizumab) Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Soliris (Eculizumab) Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Soliris (Eculizumab) Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Soliris (Eculizumab) Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 39. France Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Soliris (Eculizumab) Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Soliris (Eculizumab) Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Soliris (Eculizumab) Consumption Value Market Share by Region (2018-2029)
Figure 46. China Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 49. India Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Soliris (Eculizumab) Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Soliris (Eculizumab) Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Soliris (Eculizumab) Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Soliris (Eculizumab) Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Soliris (Eculizumab) Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Soliris (Eculizumab) Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Soliris (Eculizumab) Consumption Value (2018-2029) & (USD Million)
Figure 63. Soliris (Eculizumab) Market Drivers
Figure 64. Soliris (Eculizumab) Market Restraints
Figure 65. Soliris (Eculizumab) Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Soliris (Eculizumab) in 2022
Figure 68. Manufacturing Process Analysis of Soliris (Eculizumab)
Figure 69. Soliris (Eculizumab) Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
